
Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Hope S. Rugo, MD
Date of Release
May 14th, 2025